Warfarin Sodium

   
Google
 
Web NewDrugInformation.com

Warfarin Sodium


Drug - Warfarin Sodium
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Warfarin Sodium
Multiple ingredients are in alphabetical order.

Strength - 6MG
The potency of the active ingredient(s), Warfarin Sodium. May repeat for multiple part products.

Applicant - SANDOZ
The firm name holding legal responsibility for Warfarin Sodium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040196
The FDA assigned number to Warfarin Sodium. Format is nnnnnn.

Product Number - 009
The FDA assigned number to identify Warfarin Sodium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 26, 2000
The date Warfarin Sodium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Warfarin Sodium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Warfarin Sodium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sandoz Inc
The full name of the firm holding legal responsibility for the new application of Warfarin Sodium.

Warfarin Sodium